The U.S. cold, cough, and sore throat remedies market is driven by a diverse range of factors, including the incidence of colds and flu, growth in the child, senior, female, and Hispanic populations, and a growing trend to self-diagnose and self-treat minor ailments. Beyond analysis of these drivers, this report also offers extensive examination of the following:
Competition from natural and homeopathic remedies, which have steadily gained popularity in the U.S., and OTC remedy manufacturers’ attempts to capitalize on the trend
The evident desire among sufferers for more single-symptom remedies, which is only recently being met by manufacturers
The role of pharmacies in attracting customers to the OTC remedy aisle
The damage done to the market by infant product recalls, FDA restrictions, and decreasing consumer confidence in the safety and efficacy of OTC treatments